Profile
Petr Kocis has worked as a Vice President-Preclinical Development at Alzheon, Inc. since 2015.
Petr Kocis active positions
| Companies | Position | Start |
|---|---|---|
| ALZHEON, INC. | Corporate Officer/Principal | 2014-12-31 |
Experiences
Positions held
Connections
13
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
- Stock Market
- Insiders
- Petr Kocis
